Releases
19. June, 2025
Strengthening Executive Management with the promotion of Martin Juhl
On 19 June – Cessatech A/S (“Cessatech” or “the Company”) and the Board of...
Releases
11. June, 2025
Completion of the directed issue of shares
As announced on 28 May 2025, the Board of directors in Cessatech exercised an...
Facts
7. June, 2025
Paediatric pain in the ambulance is still being under-treated
When a child is in acute pain, minutes matter and so does the experience...
Releases
28. May, 2025
Positive top-line results from its final CT001 Study 0202
On 28 May – Cessatech A/S (“Cessatech” or “the Company”) announces top-line results from...
Releases
15. May, 2025
Financial Report Q1-2025
The Company has advanced well with its planned activities Positive CT001 MDR assessment Finalization...
Releases
30. April, 2025
Recruitment has completed in the Paediatric Study 0202
30150 paediatric patients have been recruited in Study 0202 as planned Study 0202 is...
Releases
Facts
6. March, 2025
Paediatric ED pain is still undertreated – the need for training and more treatment options
Pediatric pain management is a constantly developing field. Despite extensive research, several studies have...
Releases
28. February, 2025
Annual Report 2024
Today, Friday 28. February, Cessatech has released the Annual Report for 20024. We have...
Releases
4. February, 2025
Positive Notified Body opinion under MDR for CT001
On 4 February – Cessatech A/S (“Cessatech” or “the Company”) announces that the Company...
Releases
16. October, 2024
Halfway milestone patient recruitment in Paediatric Study 0202
Cessatech announces that recruitment has today reached the halfway point for patient recruitment with...
Releases
26. August, 2024
Cessatech and Proveca announce world-wide excluding US commercial partnership for CT001
Cessatech and Proveca enter an exclusive agreement for the commercialization of CT001 world-wide excluding...